Skip to main content

FDA Approval: Novel Formulation for Treatment of Schizophrenia

By November 11, 2025Collaboration Success Stories1 min read

Driving FDA Approvals with Precision and Speed

Discover how CRC’s expertise in clinical trial management supported the FDA approval of a novel formulation for schizophrenia treatment. Download the full case study to explore the challenges faced, proactive solutions implemented, and the strategic approach that delivered results on time and on budget.

Download the Full Case Study

Related Posts

Collaboration Success Stories Mastering Agitation Endpoints with Assessment Expertise

Mastering Agitation Endpoints with Assessment Expertise

Consistent, high-quality assessments are essential in agitation trials. In this focused case study, see how…
cogres1
cogres1July 30, 2025
Collaboration Success Stories Seamless Execution Across Early-Phase Alzheimer’s Trials

Seamless Execution Across Early-Phase Alzheimer’s Trials

In the face of pandemic-era recruitment barriers and aggressive timelines, CRC partnered with a sponsor…
cogres1
cogres1July 15, 2025
Collaboration Success Stories Expedited Completion of a Complex Driving Study

Expedited Completion of a Complex Driving Study

Driving In the Fast Lane Discover how CRC leveraged our proprietary driving simulator to swiftly…
cogres1
cogres1March 26, 2025

Leave a Reply

Share

Own the Questions.

Lead the Outcome.

Download CRC’s Deck of Questions and take control of your CRO selection process with clarity, confidence, and zero wasted motion.